The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Trial Profile

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Completed
Phase of Trial: Phase 0

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs PG 2 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Sponsors PhytoHealth
  • Most Recent Events

    • 25 Sep 2017 New trial record
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top